U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice

Brain Research

Volumn 856, Issue 1-2, 2000, Pages 259-280

  Wall, Philip M ^a   Messier, Claude ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anxiety; Elevated plus maze; Immediate working memory; Infralimbic cortex; Kappa agonist; Memory; Opioid; Y maze

Indexed keywords

KAPPA OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE;

ANIMAL EXPERIMENT; ANXIETY; CONTROLLED STUDY; DRUG EFFECT; LEARNING; LIMBIC CORTEX; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; WORKING MEMORY;

EID: 0033968978     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01990-3     Document Type: Article

References (155)

1. M. Carli et al., Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat, Eur. J. Pharmacol. 234 (2) (1993) 215-221.
2. F.C. Colpaert, Amnesic trace locked into the benzodiazepine state of memory, Psychopharmacology 102 (1) (1990) 28-36.
3. R.J. McNally, Automaticity and the anxiety disorders, Behav. Res. Ther. 33 (7) (1995) 747-754.
4. S.K. Bhattacharya et al., Anxiolytic activity of piracetam, a nootropic agent, following subchronic administration in rodents, Indian J. Exp. Biol. 31 (11) (1993) 902-907.
5. R. Frussa-Filho et al., Evaluation of memory and anxiety in rats observed in the elevated plus-maze: effects of age and isolation, Braz. J. Med. Biol. Res. 24 (7) (1991) 725-728.
6. P.A. Gargiulo et al., Effects of anxiety and memory of systemic and intra-amygdala injection of 5-HT3 receptor antagonist BRL 46470A, Neuropsychobiology 33 (4) (1996) 189-195.
7. E.G. Graeff, M.B. Viana, C. Tomaz, The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam, Braz. J. Med. Biol. Res. 26 (1) (1993) 67-70.
8. M.B. Viana, C. Tomaz, E.G. Graeff, The elevated T-maze: a new animal model of anxiety and memory, Pharmacol. Biochem. Behav. 49 (3) (1994) 549-554.
9. I. Lucki, K. Rickels, The effect of anxiolytic drugs on memory in anxious subjects, Psychopharmacol. Ser. 6 (1988) 128-139.
10. M.B. Scharf, K. Fletcher, J.P. Graham, Comparative amnestic effects of benzodiazepine hypnotic agents, J. Clin. Psychiatry 49 (4) (1988) 134-137.
11. R.D. Withers, F.F. Deane, Origins of common fears: effects on severity, anxiety responses and memories of onset, Behav. Res. Ther. 33 (8) (1995) 903-915.
12. J.E. Le Doux, Brain mechanisms of emotion and emotional learning, Curr. Opin. Neurobiol. 2 (2) (1992) 191-197.
13. J.E. Le Doux, Emotional memory systems in the brain, Behav. Brain Res. 58 (1) (1993) 69-79.
14. J.E. LeDoux, Emotional memory: in search of systems and synapses, Ann. N.Y. Acad. Sci. 702 (1993) 149-157.
15. J.E. LeDoux, Emotion: clues from the brain, Annu. Rev. Psychol. 46 (1995) 209-235.
16. E.T. Rolls, A theory of emotion and consciousness, and its application to understanding the neural basis of emotion, in the cognitive neurosciences, S.G. Michael (Ed.), MIT Press, Cambridge, MA, 1995, pp. 1091-1106.
17. M. Davis, D. Rainnie, M. Cassell, Neurotransmission in the rat amygdala related to fear and anxiety, Trends Neurosci. 17 (5) (1994) 208-214.
18. J. Schulkin, B.S. McEwen, P.W. Gold, Allostasis, amygdala, and anticipatory angst, Neurosci. Biobehav. Rev. 18 (3) (1994) 385-396.
19. J.A. Gray, The neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system, Oxford Psychology Series, Oxford: Clarendon Press, 1982.
20. J.A. Gray, N. McNaughton, Comparison between the behavioural effects of septal and hippocampal lesions: a review, Neurosci. Biobehav. Rev. 7 (2) (1983) 119-188.
21. J.A. Gray, A theory of anxiety: the role of the limbic system, Encephale 9 (4) (1983) 161B-166B.
22. C. Pesold, D. Treit, Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests, Physiol. Behav. 52 (1) (1992) 37-47.
23. D. Treit, C. Pesold, Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action, Physiol. Behav. 47 (2) (1990) 365-371.
24. C. Messier, P.M. Wall, K. Ethier, Contribution of cholinergic and gabaergic functions to memory processes in BALB/cANnCrIBR mice, Brain Res. 818 (2) (1999) 583-592.
25. A.L. Markowska, D.S. Olton, B. Givens, Cholinergic manipulations in the medial septal area: age-related effects on working memory and hippocampal electrophysiology, J. Neurosci. 15 (3Pt. 1) (1995) 2063-2073.
26. M. Ohno, T. Yamamoto, S. Watanabe, Blockade of hippocampal Ml muscarinic receptors impairs working memory performance of rats, Brain Res. 650 (2) (1994) 260-266.
27. S. Granon et al., Working memory, response selection, and effortful processing in rats with medial prefrontal lesions, Behav. Neurosci. 108 (5) (1994) 883-891.
28. S. Granon et al., Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing, Psychopharmacology (Berl.) 119 (2) (1995) 139-144.
29. B. Kolb et al., Dissociation of the medial prefrontal, posterior parietal, and posterior temporal cortex for spatial navigation and recognition memory in the rat, Cereb. Cortex. 4 (6) (1994) 664-680.
30. J. Grafman, Similarities and distinctions among current models of prefrontal cortical functions, Ann. N.Y. Acad. Sci. 769 (1995) 337-368.
31. E.F. Espejo, Selective dopamine depletion within the medial prefrontal cortex induces anxiogenic-like effects in rats placed on the elevated plus maze, Brain Res. 762 (1) (1997) 281-284.
32. P.M. Wall, Intracerebral Administration of U-69,593 and norBNI in the Medial Prefrontal Cortex and the Ventral Tegmental Area of CD-1 Mice: Behavioural Evaluation in the Elevated Plus Maze, Psychology (Neuroscience), Carleton University: Ottawa, 1997.
33. M. Gabriel, Functions of anterior and posterior cingulate cortex during avoidance learning in rabbits, Prog. Brain Res. 85 (1990) 467-482.
34. A.J. Verberne, N.C. Owens, Cortical modulation of the cardiovascular system, Prog. Neurobiol. 54 (2) (1998) 149-168.
35. M. Takagishi, T. Chiba, Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study, Brain Res. 566 (1) (1991) 26-39.
36. R.A. Dampney et al., Role of ventrolateral medulla in vasomotor regulation: a correlative anatomical and physiological study, Brain Res. 249 (2) (1982) 223-235.
37. K. Semba, H.C. Fibiger, Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study, J. Comp. Neurol. 323 (3) (1992) 387-410.
38. N.L. Rempel-Clower, H. Barbas, Topographic organization of connections between the hypothalamus and prefrontal cortex in the rhesus monkey, J. Comp. Neurol. 398 (3) (1998) 393-419.
39. S.R. Sesack et al., Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin, J. Comp. Neurol. 290 (2) (1989) 213-242.
40. T.M. Jay, M.P. Witter, Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin, J. Comp. Neurol. 313 (4) (1991) 574-586.
41. K.G. Ruit, E.J. Neafsey, Cardiovascular and respiratory responses to electrical and chemical stimulation of the hippocampus in anesthetized and awake rats, Brain Res. 457 (2) (1988) 310-321.
42. K.G. Ruit, E.J. Neafsey, Hippocampal input to a 'visceral motor' corticobulbar pathway: an anatomical and electrophysiological study in the rat, Exp. Brain Res. 82 (3) (1990) 606-616.
43. R.J. Frysztak, E.J. Neafsey, The effect of medial frontal cortex lesions on cardiovascular conditioned emotional responses in the rat, Brain Res. 643 (1) (1994) 181-193.
44. N.C. Owens, A.J. Verberne, An electrophysiological study of the medial prefrontal cortical projection to the nucleus of the solitary tract in rat, Exp. Brain Res. 110 (1) (1996) 55-61.
45. D. Joel et al., Effects of electrolytic lesions of the medial prefrontal cortex or its subfields on 4-arm baited, 8-arm radial maze, two-way active avoidance and conditioned fear tasks in the rat, Brain Res. 765 (1) (1997) 37-50.
46. M.A. Morgan, L.M. Romanski, J.E. LeDoux, Extinction of emotional learning: contribution of medial prefrontal cortex, Neurosci. Lett. 163 (1) (1993) 109-113.
47. M.E. Ragozzino, S. Adams, R.P. Kesner, Differential involvement of the dorsal anterior cingulate and prelimbic-infralimbic areas of the rodent prefrontal cortex in spatial working memory, Behav. Neurosci. 112 (2) (1998) 293-303.
48. R.P. Kesner et al., Prefrontal cortex and working memory for spatial response, spatial location, and visual object information in the rat, Cereb. Cortex. 6 (2) (1996) 311-318.
49. W.E. DeCoteau, R.P. Kesner, J.M. Williams, Short-term memory for food reward magnitude: the role of the prefrontal cortex, Behav. Brain Res. 88 (2) (1997) 239-249.
50. G. Wortwein, J. Mogensen, I. Divac, Retention and relearning of spatial delayed alternation in rats after combined or sequential lesions of the prefrontal and parietal cortex, Acta Neurobiol. Exp. 53 (2) (1993) 357-366.
51. J.J. Waite, L.J. Thal, Lesions of the cholinergic nuclei in the rat basal forebrain: excitotoxins vs. an immunotoxin, Life Sci. 58 (22) (1996) 1947-1953.
52. L.M. Broersen et al., Effects of local application of dopaminergic drugs into the dorsal part of the medial prefrontal cortex of rats in a delayed matching to position task: comparison with local cholinergic blockade, Brain Res. 645 (1) (1994) 113-122.
53. L.M. Broersen et al., Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, Biol. Psychiatry 40 (11) (1996) 1083-1090.
54. G.E. Jaskiw, D.R. Weinberger, Ibotenic acid lesions of the medial prefrontal cortex potentiate FG-7142-induced attenuation of exploratory activity in the rat, Pharmacol. Biochem. Behav. 36 (3) (1990) 695-697.
55. A.L. Jinks, I.S. McGregor, Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat, Brain Res. 772 (1) (1997) 181-190.
56. K. Tohyama et al., Involvement of GABAergic systems in benzodiazepine-induced impairment of passive avoidance learning in mice, Psychopharmacology 105 (1) (1991) 22-26.
57. C. Mathis, S.M. Paul, J.N. Crawley, Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice, Behav. Genet. 24 (2) (1994) 171-180.
58. J.D. Brioni et al., Anxiolytic-like effects of the novel cholinergic channel activator ABT-418, J. Pharmacol. Exp. Ther. 271 (1) (1994) 353-361.
59. S.P. Arneric et al., (S)-3-methyl-5-(l-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I In vitro characterization, J. Pharmacol. Exp. Ther. 270 (1) (1994) 310-318.
60. F.S. Guimaraes et al., Hippocampal 5-HT receptors and consolidation of stressful memories, Behav. Brain Res. 58 (1) (1993) 133-139.
61. M.C. Scorza, Behavioral effects of the putative anxiolytic (±)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice, Pharmacol. Biochem. Behav. 54 (2) (1996) 355-361.
62. B.L. Murphy et al., Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment, J. Neurosci. 16 (23) (1996) 7768-7775.
63. M. Ukai, N. Shinkai, T. Kameyama, Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice, Eur. J. Pharmacol. 350 (1) (1998) 39-45.
64. J.D. Jentsch et al., Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat, Neuropsychopharmacology 17 (2) (1997) 92-99.
65. R.E. Adamec, T. Shallow, J. Budgell, Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder, Behav. Neurosci. 111 (2) (1997) 435-449.
66. M. Derrien et al., The selective CCK-B agonist, BC 264, impairs socially reinforced memory in the three-panel runway test in rats, Behav. Brain Res. 65 (2) (1994) 139-146.
67. J. Sandin et al., Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect [In Process Citation], Neuroscience 85 (2) (1998) 375-382.
68. C. Castellano et al., Effects of naloxone and naltrexone on memory consolidation in CD1 mice: involvement of GABAergic mechanisms, Pharmacol. Biochem. Behav. 32 (2) (1989) 563-567.
69. C. Castellano, I.B. Introini-Collison, J.L. McGaugh, Interaction of beta-endorphin and GABAergic drugs in the regulation of memory storage, Behav. Neural. Biol. 60 (2) (1993) 123-128.
70. K.L. McDaniel, W.R. Mundy, H.A. Tilson, Microinjection of dynorphin into the hippocampus impairs spatial learning in rats, Pharmacol. Biochem. Behav. 35 (2) (1990) 429-435.
71. M. Hiramatsu et al., Effects of U-50.488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats, J. Pharmacol. Exp. Ther. 284 (3) (1998) 858-867.
72. A. Agmo, C. Belzung, The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide, Neuropharmacology 37 (2) (1998) 223-232.
73. R. Bals-Kubik et al., Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats, J. Pharmacol. Exp. Ther. 264 (1) (1993) 489-495.
74. M. Hiramatsu et al., Reversion of muscarinic autoreceptor agonistinduced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist, Br. J. Pharmacol. 123 (5) (1998) 920-926.
75. J.Q. Wang, A.J. Ingenito, Centrally mediated cardiovascular actions of dynorphin A(1-8) on rat hippocampal formation, J. Pharmacol. Exp. Ther. 261 (2) (1992) 678-685.
76. T.H. Privette, D.M. Terrian, Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze, Psychopharmacology (Berl.) 118 (4) (1995) 444-450.
77. C. Messier, S. Emond, K. Ethier, New techniques in stereotaxic surgery and anesthesia in the mouse, Pharmacol. Biochem. Behav., 1999 (in press).
78. J. Pitha, A. Gerloczy, A. Olivi, Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles, J. Pharm. Sci. 83 (6) (1994) 833-837.
79. R.J. Rodgers et al., Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze, Pharmacol. Biochem. Behav. 52 (4) (1995) 805-813.
80. R.G. Lister, The use of a plus-maze to measure anxiety in the mouse, Psychopharmacology 92 (2) (1987) 180-185.
81. M. Sarter, G. Bodewitz, D.N. Stephens, Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines, Psychopharmacology 94 (4) (1988) 491-495.
82. M. Hiramatsu, T. Hyodo, T. Kameyama, U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice, Eur. J. Pharmacol. 315 (2) (1996) 119-125.
83. M. Hiramatsu et al., Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice, Pharmacol. Biochem. Behav. 56 (1) (1997) 73-79.
84. J. Itoh, T. Nabeshima, T. Kameyama, Utility of an elevated plusmaze for dissociation of amnesic and behavioral effects of drugs in mice, Eur. J. Pharmacol. 194 (1) (1991) 71-76.
85. J. Itoh, M. Ukai, T. Kameyama, U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice, Brain Res. 619 (1) (1993) 223-228.
86. N. Andrews, S.E. File, Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety, Eur. J. Pharmacol. 235 (1) (1993) 109-112.
87. M. Derrien et al., Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens, Brain Res. 617 (2) (1993) 181-188.
88. A.P. Cruz, F. Frei, F.G. Graeff, Ethopharmacological analysis of rat behavior on the elevated plus-maze, Pharmacol. Biochem. Behav. 49 (1) (1994) 171-176.
89. C. Fernandes, S.E. File, The influence of open arm ledges and maze experience in the elevated plus-maze, Pharmacol. Biochem. Behav. 54 (1) (1996) 31-40.
90. R.J. Rodgers, N.J. Johnson, Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety, Pharmacol. Biochem. Behav. 52 (2) (1995) 297-303.
91. R. Trullas, P. Skolnick, Differences in fear motivated behaviors among inbred mouse strains, Psychopharmacology 111 (3) (1993) 323-331.
92. J.C. Cole et al., Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adren-oceptor mediation, Psychopharmacology (Berl.) 118 (4) (1995) 425-436.
93. K.B.J. Franklin, G. Paxinos, The Mouse Brain: In Stereotaxic Coordinates, Academic Press, 1997.
94. G. Di Chiara, A. Imperato, Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats, J. Pharmacol. Exp. Ther. 244 (3) (1988) 1067-1080.
95. A.M. Copland, D.J. Balfour, Spontaneous activity and brain 5-hydroxyindole levels measured in rats tested in two designs of elevated X-maze, Life Sci. 41 (1) (1987) 57-64.
96. F.D. Abercrombie et al., Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex, J. Neurochem. 52 (5) (1989) 1655-1658.
97. N. Shanks et al., Alterations of central norepinephrine, dopamine and serotonin in several strains of mice following acute stressor exposure, Pharmacol. Biochem. Behav. 38 (1) (1991) 69-75.
98. R.M. Zacharko, H. Anisman, Stressor-induced anhedonia in the mesocorticolimbic system, Neurosci. Biobehav. Rev. 15 (3) (1991) 391-405.
99. H. Kaneyuki et al., Psychological stress increases dopamine turnover selectively in mesoprefrontal dopamine neurons of rats: reversal by diazepam, Brain Res. 557 (1) (1991) 154-161.
100. M. Yoshioka et al., Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex, Pharmacol. Biochem. Behav. 51 (2) (1995) 515-519.
101. G. Di Chiara, A. Imperato, Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc. Natl. Acad. Sci. USA 85 (14) (1988) 5274-5278.
102. T. Kameyama, M. Ukai, N. Shinkai, Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice, Methods Find. Exp. Clin. Pharmacol. 20 (7) (1998) 555-560.
103. T. Maurice et al., Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia, Brain Res 647 (1) (1994) 44-56.
104. S.B. Dunnett, Role of prefrontal cortex and striatal output systems in short-term memory deficits associated with ageing, basal forebrain lesions, and cholinergic-rich grafts, Can. J. Psychol. 44 (2) (1990) 210-232.
105. A.H. Herremans et al., Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat, Brain Res. 711 (1) (1996) 102-111.
106. J. Itoh, M. Ukai, T. Kameyama, Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice, J. Pharmacol. Exp. Ther. 269 (1) (1994) 15-21.
107. M.W. Parsons, P.E. Gold, Scopolamine-induced deficits in spontaneous alternation performance: attenuation with lateral ventricle injections of glucose, Behav. Neural. Biol. 57 (1) (1992) 90-92.
108. W.S. Stone et al., Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists, Behav. Neurosci. 105 (2) (1991) 264-271.
109. M. Ukai et al., Substance P markedly ameliorates scopolamine-induced impairment of spontaneous alternation performance in the mouse, Brain Res. 673 (2) (1995) 335-338.
110. M. Ukai, N. Shinkai, T. Kameyama, Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice, Nihon Shinkei Seishin Yakurigaku Zasshi 16 (3) (1996) 97-101.
111. M. Ukai et al., Effects of the kappa-opioid dynorphin A(l-13) on learning and memory in mice, Behav. Brain Res. 83 (1) (1997) 169-172.
112. D.L. Walker et al., Naloxone modulates the behavioral effects of cholinergic agonists and antagonists, Psychopharmacology 105 (1) (1991) 57-62.
113. E. Fernandez Espejo, Structure of the mouse behaviour on the elevated plus-maze test of anxiety, Behav. Brain Res. 86 (1) (1997) 105-112.
114. S. Fellow et al., Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods 14 (3) (1985) 149-167.
115. J.M. Elliott, D.J. Heal, C.A. Marsden, Experimental approaches to anxiety and depression, Biological Council Symposia on Drug Action, Wiley, New York, 1992.
116. A. Beuzen, C. Belzung, Link between emotional memory and anxiety states: a study by principal component analysis, Physiol. Behav. 58 (1) (1995) 111-118.
117. E.G. Graeff, M.B. Viana, P.O. Mora, Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze, Pharmacol. Biochem. Behav. 53 (1) (1996) 171-177.
118. E.M. Unterwald, C. Knapp, R.S. Zukin, Neuroanatomical localization of kappa 1 and kappa 2 opioid receptors in rat and guinea pig brain, Brain Res. 562 (1) (1991) 57-65.
119. A. Mansour et al., Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, Trends Neurosci. 18 (1) (1995) 22-29.
120. E.G. Jones, S.H. Hendry, Peptide-containing neurons of the primate cerebral cortex, Res. Publ. Assoc. Res. Nerv. Ment. Dis. 64 (1986) 163-178.
121. O.A. Olson, R.D. Olson, A.J. Kastin, Endogenous opiates: 1992, Peptides 14 (6) (1993) 1339-1378.
122. J. Manzanares, K.J. Lookingland, K.E. Moore, Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain, J. Pharmacol. Exp. Ther. 256 (2) (1991) 500-505.
123. J.P. Herman et al., Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat, Life Sci. 30 (25) (1982) 2207-2214.
124. A.J. Dunn, S.E. File, Cold restraint alters dopamine metabolism in frontal cortex, nucleus accumbens and neostriatum, Physiol. Behav. 31 (4) (1983) 511-513.
125. A.Y. Deutch, R.H. Roth, The determinants of stress-induced activation of the prefrontal cortical dopamine system, Prog. Brain Res. 85 (1990) 367-402.
126. M. Bertolucci-D'Angio, A. Serrano, B. Scatton, Mesocorticolimbic dopaminergic systems and emotional states, J. Neurosci. Methods 34 (1) (1990) 135-142.
127. J.N. Carlson et al., Side and region dependent changes in dopamine activation with various durations of restraint stress, Brain Res. 550 (2) (1991) 313-318.
128. R.P. Heinsbroek et al., Controllable and uncontrollable footshock and monoaminergic activity in the frontal cortex of male and female rats, Brain Res. 551 (1) (1991) 247-255.
129. B.A. Sorg, P.W. Kalivas, Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex, Neuroscience 53 (3) (1993) 695-703.
130. B.L. Murphy et al., Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys, Proc. Natl. Acad. Sci. USA 93 (3) (1996) 1325-1329.
131. R. Spanagel, A. Herz, T.S. Shippenberg, Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway, Proc. Natl. Acad. Sci. USA 89 (6) (1992) 2046-2050.
132. E.M. Unterwald, J.M. Rubenfeld, M.J. Kreek, Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors, Neuroreport 5 (13) (1994) 1613-1616.
133. P.S. Goldman-Rakic, L.D. Selemon, Functional and anatomical aspects of prefrontal pathology in schizophrenia [see comments], Schizophr. Bull. 23 (3) (1997) 437-458.
134. T.W. Robbins, The case of frontostriatal dysfunction in schizophrenia, Schizophr. Bull. 16 (3) (1990) 391-402.
135. F.X. Castellanos, Toward a pathophysiology of attention-deficit/hyperactivity disorder, Clin. Pediatr. (Phila.) 36 (7) (1997) 381-393.
136. V. Russell et al., Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder - the spontaneously hypertensive rat, Brain Res. 676 (2) (1995) 343-351.
137. M. Ernst et al., DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study, J. Neurosci. 18 (15) (1998) 5901-5907.
138. A.M. Gotham, R.G. Brown, C.D. Marsden, 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off levodopa, Brain 111 (Pt.2) (1988) 299-321.
139. B.J. Carroll, J.E. Barrett, American Psychopathological Association, Meeting: Psychopathology and the brain, American Psychopathological Association series, Raven Press, New York, 1991.
140. M. Bubser, W.J. Schmidt, 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze, Behav. Brain Res. 37 (2) (1990) 157-168.
141. T.J. Brozoski et al., Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey, Science 205 (4409) (1979) 929-932.
142. H. Simon, B. Scatton, M.L. Moal, Dopaminergic A10 neurones are involved in cognitive functions, Nature 286 (5769) (1980) 150-151.
143. T. Sawaguchi, P.S. Goldman-Rakic, D1 dopamine receptors in prefrontal cortex: involvement in working memory, Science 251 (4996) (1991) 947-950.
144. T. Sawaguchi, P.S. Goldman-Rakic, The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task, J. Neurophysiol. 71 (2) (1994) 515-528.
145. J.K. Seamans, S.B. Floresco, A.G. Phillips, D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat, J. Neurosci. 18 (4) (1998) 1613-1621.
146. G.H. Jones, T.W. Robbins, Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity, Pharmacol. Biochem. Behav. 43 (3) (1992) 887-895.
147. M.E. Ragozzino, R.P. Kesner, The effects of muscarinic cholinergic receptor blockade in the rat anterior cingulate and Prelimbic/Infralimbic cortices on spatial working memory, Neurobiol. Learn. Mem. 69 (3) (1998) 241-257.
148. M.E. Ragozzino, K.E. Unick, P.E. Gold, Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose, Proc. Natl. Acad. Sci. USA 93 (10) (1996) 4693-4698.
149. E. Acquas, C. Wilson, H.C. Fibiger, Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear, J. Neurosci. 16 (9) (1996) 3089-3096.
150. G.P. Mark, P.V. Rada, T.J. Shors, Inescapable stress enhances extracellular acetylcholine in the rat hippocampus and prefrontal cortex but not the nucleus accumbens or amygdala, Neuroscience 74 (3) (1996) 767-774.
151. R.J. Rodgers, J.C. Cole, Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety, Behavioural Pharmacology 6 (3) (1995) 283-289.
152. J. Itoh, M. Ukai, T. Kameyama, Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice, Eur. J. Pharmacol. 236 (3) (1993) 341-345.
153. Y. Izaki, K. Hori, M. Nomura, Dopamine and acetylcholine elevation on lever-press acquisition in rat prefrontal cortex [In Process Citation], Neurosci. Lett. 258 (1) (1998) 33-36.
154. T.D. Steele, The Dl agonist dihydrexidine releases acetylcholine and improves cognition in rats, Ann. N.Y. Acad. Sci. 777 (1996) 427-430.
155. M. Belotti, D. Galey, Consequences of selective blockade of septal noradrenergic afferents on anxiety and spatial working memory performance in mice, Pharmacol. Biochem. Behav. 53 (3) (1996) 541-547.